Trial
NCT01313884
Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
Amgen
Condition
Bone Cancer
Intervention
Irinotecan
Why stopped
Study did not reach primary objective; study did not accrue enough patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-24